Expandable prosthetic devices used for treating a variety of conditions, including rotator cuff injuries, broken and/or depressed bone fractures, infection and/or inflammation in the body. In one embodiment, a prosthesis includes an implant having a pressure regulating valve. The implant is capable of being positioned between a first tissue and an opposing second tissue in a void space and of deforming under pressure in response to articulation of a joint. The pressure regulating valve is configured to open based on a predetermined pressure in the implant.

A selectively expanding spine cage has a minimized cross section in its unexpanded state that is smaller than the diameter of the neuroforamen through which it passes in the distracted spine. The cage conformably engages between the endplates of the adjacent vertebrae to effectively distract the anterior disc space, stabilize the motion segments and eliminate pathologic spine motion. Expanding selectively (anteriorly, along the vertical axis of the spine) rather than uniformly, the cage height increases and holds the vertebrae with fixation forces greater than adjacent bone and soft tissue failure forces in natural lordosis. Stability is thus achieved immediately, enabling patient function by eliminating painful motion. The cage shape intends to rest proximate to the anterior column cortices securing the desired spread and fixation, allowing for bone graft in, around, and through the implant for arthrodesis whereas for arthroplasty it fixes to endpoints but cushions the spine naturally.

Disclosed are a self-switching transmission assembly, a balloon, and a prosthesis for use in a shoulder joint. The self-switching transmission assembly comprises: a communicating tube (11, 11′, 11″) comprising an input end (111, 111′, 111″) and an output end (112, 112′, 112″); an external connection tube (12, 12′, 12″), an end portion thereof being insertable into the communicating tube (11, 11′, 11″) from the input end (111, 111′, 111″) and removable from the communicating tube (11, 11′, 11″) from the input end (111, 111′, 111″); and a sealing tube (13, 13′, 13″), which can be placed in a tube body of the communicating tube (11, 11′, 11″) and moved axially relative to the tube body of the communicating tube (11, 11′, 11″). The sealing tube (13, 13′, 13″) comprises a connection end (131, 131′, 131″) and a sealing end (132, 132′, 132″), the connection end (131, 131′, 131″) being detachably connected to the end portion of the external connection tube (12, 12′, 12″) by means of a connection driving mechanism, and the sealing end (132, 132′, 132″) being provided with a pass-through region, wherein, when the pass-through region is exposed outside of the output end (112, 112′, 112″), the self-switching transmission assembly is in a pass-through state, and when the pass-through region is placed inside the tube body of the communicating tube (11, 11′, 11″), the self-switching transmission assembly is in a sealed and blocked state.

Disclosed are an automatic control system for urinary incontinence with a function of multi-point switching in turn and an intracorporeal apparatus (200) thereof. The intracorporeal apparatus (200) is completely implanted in a body. The intracorporeal apparatus (200) comprises an intracorporeal microcontroller (220) and urethral blockers (230), the intracorporeal microcontroller (220) being configured to control the urethral blockers (230) to block and unblock the urethra. The intracorporeal apparatus (200) comprises at least two urethral blockers (230) provided at different locations on the urethra, i.e., a first urethral blocker (230a) and a second urethral blocker (230b), and the intracorporeal microcontroller (220) is configured to control the at least two urethral blockers (230) to block and unblock the urethra in turn.

An accommodative intraocular lens includes an optic body having an optical power changing structure. There are two supporting structures disposed opposite one another about the optic body, each supporting structure configured to be connected at a distal end to a ciliary body after implantation in an eye of a patient and connected at a proximal end to the optic body. The two supporting structures are a zeroing supporting structure and an actuating supporting structure. The zeroing supporting structure is configured to not change the optical power of the optic body in an installation mode and an operation mode of the accommodative intraocular lens. An actuating supporting structure is configured to not change the optical power of the optic body in the installation mode but is configured to change the optical power of the optic body in the operation mode of the accommodative intraocular lens.

Systems, methods, and devices for inserting an intraocular lens (IOL) into an eye may be provided. An example haptic optic management system may comprise a first cam assembly comprising a first cam body portion, an opening in the first cam body portion, and haptic folder arms disposed in the opening. The haptic optic management system may further comprise a second cam assembly positioned on one side of the first cam assembly, wherein the second cam assembly comprises a second cam body portion, an opening in the second cam body portion, and optic folders disposed in the opening. The haptic optic management system may further comprise a central plate for holding an intraocular lens in the opening of the second cam body portion, wherein the central plate is disposed between the first cam assembly and the second cam assembly.

The invention relates to an assembly formed by a medical device (1) adapted to be implanted in a human or animal body and by packaging, wherein: te medical device comprises a housing (11) that encloses a fluid reservoir (13) and a fluid outlet (12) forming a fluid connection between the reservoir and a volume outside the housing; the packaging includes a tank (2) comprising a bottom (20), a side wall (21), an upper face opposite the bottom in a vertical direction, and an opening configured to fill the tank with a biocompatible fluid, the bottom (20) of the tank extending in a horizontal plane perpendicularly to the vertical direction; at least one of the bottom, the side wall and the top face comprises a first holding element (201) adapted to hold the housing in the tank, the housing (11) being held in the tank (2) by said first holding element (201) such that the reservoir is located between the bottom of the tank and the fluid outlet, said fluid outlet being arranged below the opening such that the fluid outlet is immersed in the fluid when the tank is filled with the biocompatible fluid.

Implantable transponders comprising no ferromagnetic parts for use in medical implants are disclosed herein. Such transponders may assist in preventing interference of transponders with medical imaging technologies. Such transponders may optionally be of a small size, and may assist in collecting and transmitting data and information regarding implanted medical devices. Methods of using such transponders, readers for detecting such transponders, and methods for using such readers are also described.

The present disclosure describes various embodiments of adjustable implants, particularly permanent breast implants, intended for implantation into a subject, particularly a human subject. In some embodiments, the adjustable implant comprises a shell including a resilient shell membrane, a first reservoir containing a fluid, e.g., a saline, a second reservoir including a resilient second-reservoir membrane, and a pump. The pump may include a first pump actuator, a first pump inlet, and a first pump outlet. The first reservoir and second reservoir may be disposed within the shell and be in fluid communication via the pump. Fluid may be transferred between the two reservoirs to change the profile of the implant.

Aspects of the disclosure provide a cardiac implant delivery device including catheter having a distal end and a telescoping capsule assembly secured to the distal end. The capsule assembly can include a distal capsule and a proximal capsule. Other embodiments include additional capsules positioned between the proximal and distal capsules. The capsule assembly has a loaded arrangement and a deployed arrangement. As the capsule assembly transitions from the loaded arrangement fully covering the implant to the deployed arrangement, the proximal capsule and any intermediate capsules move distally in the direction of the distal capsule to unsheathe the implant. In various embodiments, the cardiac implant is a prosthetic heart valve. Methods of delivering a cardiac implant are also disclosed. Various methods include methods of delivering a replacement tricuspid heart valve.